Quick Answer
Immunocore Holdings plc reported Total Assets of $1.07 billion for fiscal year 2025.
Immunocore Holdings plc Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $1.07B | +5.7% |
| 2024 | $1.01B | +69.1% |
| 2023 | $597.00M | +13.3% |
| 2022 | $526.76M | +74.6% |
| 2021 | $301.77M | +53.0% |
| 2020 | $197.19M | +6.2% |
| 2019 | $185.65M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $1.10B | +1.6% | +1.9% |
| June 30, 2025 | $1.08B | +5.8% | +5.3% |
| March 31, 2025 | $1.03B | +3.4% | +1.8% |
| December 31, 2024 | $1.01B | +69.1% | -6.9% |
| September 30, 2024 | $1.08B | — | +6.0% |
| June 30, 2024 | $1.02B | — | +3.0% |
| March 31, 2024 | $993.99M | — | +66.5% |
| December 31, 2023 | $597.00M | — | — |
- Immunocore Holdings plc showed an increase of +5.7% in Total Assets compared to the prior fiscal year.
- Over the 2019–2025 period, Immunocore Holdings plc’s total assets has grown by 474.9% (from $185.65 million to $1.07 billion).
- The most recent figure is from Immunocore Holdings plc’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 25, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: